Danaher Corporation's (DHR) stock price currently stands at $177.37, witnessing a decrease of $3.25 (-1.8%) from the previous close of $180.62. Today's trading volume is at $1 million, representing a 24.28% increase compared to the average volume.
In the latest quarterly earnings report on Monday, April 20th, DHR reported earnings per share of $1.94, meeting the consensus estimate.
DHR offers a forward dividend yield of 0.902%, with a dividend per share of 40 cents both on a quarterly and trailing twelve months basis.
Morgan Stanley's recent analysis on April 22nd maintained an "Overweight" grade for DHR, suggesting a hold action at a price of $184.04.
The company's free cash flow stands at $1 billion, with a net change in cash of $1 billion. Operating cash flow for the period is reported at $1.32 billion.
DHR reported a revenue of $5.95 billion, resulting in a net income of $1 billion. Earnings per share (EPS) and EPS diluted are both noted at $1.45.
Key ratios for DHR include a net profit margin of 17.29%, return on equity of 1.94%, and a price-to-earnings ratio of 31.22.
The balance sheet reflects total assets of $83.54 billion, total liabilities of $30.59 billion, and net debt of $12.78 billion.
This real-time financial report provides insights into DHR's current performance and financial health.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.